Progenity®. Prepare for life.

Previous View More
Effective June 18, Progenity will no longer accept patient specimens for testing. Learn more about our strategic transformation Results from key study for Progenity’s Targeted Therapeutics Program Learn More Progenity provides key update for Preecludia™ Preeclampsia Rule-Out Test Learn More Sean Lavin, MD joins Progenity as VP, Business Development, Strategy & Investor Relations Learn More Progenity announces poster presentations at Digestive Disease Week Learn More

Transforming healthcare to be more precise and personal.

Our genetic testing products improve lives by providing actionable information that helps patients and providers make informed medical decisions.

Planning for a Baby Learn your genetic carrier status to prepare for parenthood.A smiling couple walking, embraced. Prenatal Testing Uncover information about your baby's health before birth.A woman showing a picture of a sonogram. Cancer Risk Evaluation Evaluate hereditary cancer risk for early detection & preventionThree people walking on the beach.

Our Products

The Progenity Care Team Difference

We provide personalized, timely, one-on-one support for patients and healthcare providers. Our US-based team of account representatives, genetic counselors, and client advocates are standing by to help you every step of the way.

Guideline-driven tests with proven performance

With over 2 million tests processed since 2011, healthcare providers and patients trust Progenity with their genetic testing needs. Our guideline-driven tests help you to deliver the highest standard of care possible.

Commitment to Patient Education

A patient's ability to interpret health-related information may impact health outcomes. All of our patient education materials are optimized for readability and available in digital formats to allow easy sharing with patients.

Innovative Product Pipeline

We recently launched our Clinical Experience Study for the Preecludia™ Rule-Out Test for Preeclampsia. We are also focused on medicine through novel diagnostics and therapeutics under development, with an initial focus on disorders of the gastrointestinal (GI) tract.

Two employees working in the lab.

We are a specialty biotech company that features a multiomic platform of molecular testing products.

We continue to drive innovation with our R&D pipeline featuring testing products for women's health and technologies to advance gastrointestinal precision medicine.

About Us

Latest News

View All News

Featured Publications

View All Publications
Filters
Results Per Page